Public Profile

Xbrane Biopharma AB

Xbrane Biopharma AB, a pioneering biotechnology company headquartered in Sweden, focuses on the development of innovative biosimilars and biologics. Founded in 2006, Xbrane has made significant strides in the biopharmaceutical industry, particularly in the fields of ophthalmology and oncology. The company is renowned for its flagship product, Xlucane, a biosimilar to Lucentis, which addresses serious eye diseases and showcases Xbrane's commitment to enhancing patient care through affordable treatment options. With a strong presence in Europe and expanding operations globally, Xbrane Biopharma has established itself as a key player in the biosimilar market, recognised for its rigorous development processes and high-quality standards. As Xbrane continues to advance its pipeline, it remains dedicated to delivering innovative solutions that meet the evolving needs of healthcare providers and patients alike.

DitchCarbon Score

How does Xbrane Biopharma AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Xbrane Biopharma AB's score of 37 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.

96%

Let us know if this data was useful to you

Xbrane Biopharma AB's reported carbon emissions

In 2023, Xbrane Biopharma AB reported total emissions of approximately 9,000 kg CO2e, with 8,000 kg CO2e attributed to Scope 2 emissions. This marks a reduction from 2022, when the company recorded 10,000 kg CO2e in Scope 2 emissions alone, with no Scope 1 emissions reported. Xbrane has set ambitious climate commitments, aiming to reduce its Scope 1 emissions to near zero by 2025. Additionally, the company plans to cut its Scope 2 emissions by 50% from a 2020 baseline by 2030, with a target to also achieve near-zero Scope 2 emissions by 2025. These initiatives reflect Xbrane's commitment to sustainability and reducing its carbon footprint in the biopharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
-
-
Scope 2
10,000
0,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Xbrane Biopharma AB's primary industry is Education services (80), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Xbrane Biopharma AB is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Xbrane Biopharma AB is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Formycon AG

DE
Health and social work services (85)
Updated 1 day ago

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Celltrion

KR
Research and development services (73)
Updated 1 day ago

Samsungbioepis Co,.Ltd

KR
Research and development services (73)
Updated 1 day ago

Fresenius

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Amgen

US
Chemicals nec
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers